GB1181003A - Therapeutic Compositions - Google Patents

Therapeutic Compositions

Info

Publication number
GB1181003A
GB1181003A GB03049/67A GB1304967A GB1181003A GB 1181003 A GB1181003 A GB 1181003A GB 03049/67 A GB03049/67 A GB 03049/67A GB 1304967 A GB1304967 A GB 1304967A GB 1181003 A GB1181003 A GB 1181003A
Authority
GB
United Kingdom
Prior art keywords
resin
sieve
polystyrene
equililination
divinylbenzene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB03049/67A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mead Johnson and Co LLC
Original Assignee
Mead Johnson and Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mead Johnson and Co LLC filed Critical Mead Johnson and Co LLC
Priority to GB03049/67A priority Critical patent/GB1181003A/en
Priority to FR102712A priority patent/FR6888M/fr
Publication of GB1181003A publication Critical patent/GB1181003A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L25/00—Compositions of, homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring; Compositions of derivatives of such polymers
    • C08L25/02—Homopolymers or copolymers of hydrocarbons
    • C08L25/04—Homopolymers or copolymers of styrene
    • C08L25/06—Polystyrene
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L93/00—Compositions of natural resins; Compositions of derivatives thereof

Abstract

1,181,003. Medicines containing ion-exchange resins. MEAD JOHNSON & CO. 20 March, 1967, No. 13049/67. Heading A5B. [Also in Division C3] A therapeutically useful composition comprises a major amount by wt. of a non-toxic strongly basic polystyrene anion exchange resin e.g. a quaternary ammonium chloride substituted polystyrene, cross-linked with not more than 10% by wt. of divinylbenzene and a minor amount of acacia gum, the resin having a molecular weight of >3,000, water content of at least 65% by wt. after equililination with air at 100% relative humidity, the ability to absorb glycocholic acid from aq. solutions thereof, and a particle size such that at least 90% by wt. thereof passes a 200 mesh sieve (U.S. Sieve Standard). The composition may also contain a food flavour, alginic acid salt or ester.
GB03049/67A 1967-03-20 1967-03-20 Therapeutic Compositions Expired GB1181003A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB03049/67A GB1181003A (en) 1967-03-20 1967-03-20 Therapeutic Compositions
FR102712A FR6888M (en) 1967-03-20 1967-04-14

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB03049/67A GB1181003A (en) 1967-03-20 1967-03-20 Therapeutic Compositions
FR102712A FR6888M (en) 1967-03-20 1967-04-14

Publications (1)

Publication Number Publication Date
GB1181003A true GB1181003A (en) 1970-02-11

Family

ID=26175591

Family Applications (1)

Application Number Title Priority Date Filing Date
GB03049/67A Expired GB1181003A (en) 1967-03-20 1967-03-20 Therapeutic Compositions

Country Status (2)

Country Link
FR (1) FR6888M (en)
GB (1) GB1181003A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4252790A (en) * 1974-10-23 1981-02-24 Interx Research Corporation Method for treating gastric ulcer-prone patients
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4790991A (en) * 1985-02-05 1988-12-13 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4818539A (en) * 1985-02-05 1989-04-04 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4843098A (en) * 1985-02-05 1989-06-27 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4851392A (en) * 1985-02-05 1989-07-25 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4895723A (en) * 1986-09-08 1990-01-23 Amer And Company Cholestyramine compositions and method for preparation thereof
WO1999011676A1 (en) * 1997-08-29 1999-03-11 Smithkline Beecham Plc Formulation
EP1924246B1 (en) 2005-09-15 2015-10-21 Genzyme Corporation Sachet formulation for amine polymers
US10245284B2 (en) 2015-08-19 2019-04-02 Alpex Pharma S.A. Granular composition for oral administration

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0323666B1 (en) * 1987-12-29 1992-03-25 The Procter & Gamble Company Mixed compositions for treating hypercholesterolemia
US5910317A (en) * 1988-01-11 1999-06-08 The Procter & Gamble Company Mixed compositions for treating hypercholesterolemia
CA2098199C (en) * 1990-12-20 1997-06-03 Nabil George Kardouche Psyllium and cholestyramine compositions with improved palatability
WO1993018756A1 (en) * 1992-03-20 1993-09-30 The Procter & Gamble Company Anion exchange resin compositions
US5942550A (en) * 1996-01-25 1999-08-24 The Procter & Gamble Company Cholesterol lowering drink mix compositions

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4252790A (en) * 1974-10-23 1981-02-24 Interx Research Corporation Method for treating gastric ulcer-prone patients
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4790991A (en) * 1985-02-05 1988-12-13 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4818539A (en) * 1985-02-05 1989-04-04 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4843098A (en) * 1985-02-05 1989-06-27 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4851392A (en) * 1985-02-05 1989-07-25 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4895723A (en) * 1986-09-08 1990-01-23 Amer And Company Cholestyramine compositions and method for preparation thereof
WO1999011676A1 (en) * 1997-08-29 1999-03-11 Smithkline Beecham Plc Formulation
EP1924246B1 (en) 2005-09-15 2015-10-21 Genzyme Corporation Sachet formulation for amine polymers
US10245284B2 (en) 2015-08-19 2019-04-02 Alpex Pharma S.A. Granular composition for oral administration
US10688121B2 (en) 2015-08-19 2020-06-23 Alpex Pharma S.A. Granular composition for oral administration

Also Published As

Publication number Publication date
FR6888M (en) 1969-04-21

Similar Documents

Publication Publication Date Title
GB1181003A (en) Therapeutic Compositions
ES297343A1 (en) Improvements introduced in the manufacture of beds to eliminate impurities of a liquid (Machine-translation by Google Translate, not legally binding)
ES385682A1 (en) Antifoam preparations and method of preparing same
GB2258397A (en) Pharmaceutical compositions containing amethocaine
AU1016070A (en) Improvements in or relating to 4,20,22-bufatrienoliderhamnoside-acylates and process for their manufacture
IL35434A0 (en) Basically substituted tertiary butanols,their preparation and pharmaceutical compositions containing them
IL34747A0 (en) Ergonorcornine,its 1-methyl derivative and their salts,their preparation and pharmaceutical compositions containing them
ES335690A1 (en) Improvement in the Granulation of Ammonium Nitrate for use as a Fertiliser and improved Granules obtained by the process
ES335190A1 (en) Improvements introduced in the preparation of compositions to stop welding. (Machine-translation by Google Translate, not legally binding)
CA923425A (en) Compositions containing garcinia acid
Thompson PRICE PERFORMANCE IN THIN MARKETS (FUTURES, COMMODITIES)
CA974078A (en) Process for producing granular composition for use in agriculture and horticulture
IL30181A (en) 1-(substituted phenoxy)-2-hydroxy-3-tertiary butylaminopropanes,their preparation and pharmaceutical compositions containing them
GB1187631A (en) Improvements in Tabletting Ingredients
ZA715813B (en) Improvements relating to 1,2,3,6-tetrahydro-4-pyridylmethyl-carbonic acid esters,as well as the acid addition salts and quaternary ammonium compounds thereof
Matsuura et al. On the Calcium Enrichment of Fish (Part 2) Alkalinity in Calcium Enriched Fish, affected by Freshened Salt
AU449385B2 (en) Improvements in and relating to grass catchers for mowers
CA816385A (en) Sickle bar mower
DUSHAUSKENE-DUZH et al. COEFFICIENTS OF ACCUMULATION OF STRONTIUM-90 IN CERTAIN FISH(RADIOECOLOGICAL STUDY)
JPS535246A (en) Liquid stabilizers for polyvinyl chloride
Rough A winter application of granular organosphosphorus formulations
AU450887B2 (en) Grass selective herbicide composition (additional to 416074)
Guskova Dioxidin effect of rat embryogenesis.
AU422533B2 (en) Improvements in or relating to stabilized vinyl halide resin compositions
CA811185A (en) 2,3,5,6-tetrachlorobenzoic acid and salts thereof